Table of Content

1 Urological Cancer Therapeutics Drugs Market Overview
1.1 Urological Cancer Therapeutics Drugs Product Scope
1.2 Urological Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Urological Cancer Therapeutics Drugs Segment by Application
1.3.1 Global Urological Cancer Therapeutics Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Urological Cancer Therapeutics Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Urological Cancer Therapeutics Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Urological Cancer Therapeutics Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Urological Cancer Therapeutics Drugs Price Trends (2016-2027)

2 Urological Cancer Therapeutics Drugs Estimates and Forecasts by Region
2.1 Global Urological Cancer Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Urological Cancer Therapeutics Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Urological Cancer Therapeutics Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)
2.4.3 China Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)
2.4.6 India Urological Cancer Therapeutics Drugs Estimates and Projections (2016-2027)

3 Global Urological Cancer Therapeutics Drugs Competition Landscape by Players
3.1 Global Top Urological Cancer Therapeutics Drugs Players by Sales (2016-2021)
3.2 Global Top Urological Cancer Therapeutics Drugs Players by Revenue (2016-2021)
3.3 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2020)
3.4 Global Urological Cancer Therapeutics Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Urological Cancer Therapeutics Drugs Market Size by Type
4.1 Global Urological Cancer Therapeutics Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Urological Cancer Therapeutics Drugs Price by Type (2016-2021)
4.2 Global Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2022-2027)

5 Global Urological Cancer Therapeutics Drugs Market Size by Application
5.1 Global Urological Cancer Therapeutics Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Urological Cancer Therapeutics Drugs Price by Application (2016-2021)
5.2 Global Urological Cancer Therapeutics Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Urological Cancer Therapeutics Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Urological Cancer Therapeutics Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2022-2027)

6 North America Urological Cancer Therapeutics Drugs Market Facts & Figures
6.1 North America Urological Cancer Therapeutics Drugs Sales by Company
6.1.1 North America Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
6.1.2 North America Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
6.2 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Type
6.2.1 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Application
6.3.1 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Urological Cancer Therapeutics Drugs Sales Breakdown by Application (2022-2027)

7 Europe Urological Cancer Therapeutics Drugs Market Facts & Figures
7.1 Europe Urological Cancer Therapeutics Drugs Sales by Company
7.1.1 Europe Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
7.1.2 Europe Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
7.2 Europe Urological Cancer Therapeutics Drugs Sales Breakdown by Type
7.2.1 Europe Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Urological Cancer Therapeutics Drugs Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Urological Cancer Therapeutics Drugs Market Facts & Figures
8.1 China Urological Cancer Therapeutics Drugs Sales by Company
8.1.1 China Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
8.1.2 China Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
8.2 China Urological Cancer Therapeutics Drugs Sales Breakdown by Type
8.2.1 China Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
8.3 China Urological Cancer Therapeutics Drugs Sales Breakdown by Application
8.3.1 China 164 Sales Breakdown by Application (2016-2021)
8.3.2 China 164 Sales Breakdown by Application (2022-2027)

9 Japan Urological Cancer Therapeutics Drugs Market Facts & Figures
9.1 Japan Urological Cancer Therapeutics Drugs Sales by Company
9.1.1 Japan Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
9.1.2 Japan Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
9.2 Japan Urological Cancer Therapeutics Drugs Sales Breakdown by Type
9.2.1 Japan Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Urological Cancer Therapeutics Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Urological Cancer Therapeutics Drugs Market Facts & Figures
10.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales by Company
10.1.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Urological Cancer Therapeutics Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Urological Cancer Therapeutics Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Urological Cancer Therapeutics Drugs Market Facts & Figures
11.1 India Urological Cancer Therapeutics Drugs Sales by Company
11.1.1 India Urological Cancer Therapeutics Drugs Sales by Company (2016-2021)
11.1.2 India Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021)
11.2 India Urological Cancer Therapeutics Drugs Sales Breakdown by Type
11.2.1 India Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Urological Cancer Therapeutics Drugs Sales Breakdown by Type (2022-2027)
11.3 India Urological Cancer Therapeutics Drugs Sales Breakdown by Application
11.3.1 India Urological Cancer Therapeutics Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Urological Cancer Therapeutics Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Urological Cancer Therapeutics Drugs Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Urological Cancer Therapeutics Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Urological Cancer Therapeutics Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Business Overview
12.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Astellas
12.5.1 Astellas Corporation Information
12.5.2 Astellas Business Overview
12.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Astellas Urological Cancer Therapeutics Drugs Products Offered
12.5.5 Astellas Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Business Overview
12.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Celgene Corporation
12.8.1 Celgene Corporation Corporation Information
12.8.2 Celgene Corporation Business Overview
12.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Products Offered
12.8.5 Celgene Corporation Recent Development
12.9 Dendreon Corporation
12.9.1 Dendreon Corporation Corporation Information
12.9.2 Dendreon Corporation Business Overview
12.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Products Offered
12.9.5 Dendreon Corporation Recent Development
12.10 Ferring Pharmaceuticals
12.10.1 Ferring Pharmaceuticals Corporation Information
12.10.2 Ferring Pharmaceuticals Business Overview
12.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Products Offered
12.10.5 Ferring Pharmaceuticals Recent Development
12.11 GlaxoSmithKline plc
12.11.1 GlaxoSmithKline plc Corporation Information
12.11.2 GlaxoSmithKline plc Business Overview
12.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Products Offered
12.11.5 GlaxoSmithKline plc Recent Development
12.12 Indevus Pharmaceuticals Inc
12.12.1 Indevus Pharmaceuticals Inc Corporation Information
12.12.2 Indevus Pharmaceuticals Inc Business Overview
12.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Products Offered
12.12.5 Indevus Pharmaceuticals Inc Recent Development
12.13 Ipsen
12.13.1 Ipsen Corporation Information
12.13.2 Ipsen Business Overview
12.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ipsen Urological Cancer Therapeutics Drugs Products Offered
12.13.5 Ipsen Recent Development
12.14 Roche Healthcare
12.14.1 Roche Healthcare Corporation Information
12.14.2 Roche Healthcare Business Overview
12.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Products Offered
12.14.5 Roche Healthcare Recent Development
12.15 Sanofi S.A.
12.15.1 Sanofi S.A. Corporation Information
12.15.2 Sanofi S.A. Business Overview
12.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Products Offered
12.15.5 Sanofi S.A. Recent Development

13 Urological Cancer Therapeutics Drugs Manufacturing Cost Analysis
13.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
13.4 Urological Cancer Therapeutics Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Urological Cancer Therapeutics Drugs Distributors List
14.3 Urological Cancer Therapeutics Drugs Customers

15 Market Dynamics
15.1 Urological Cancer Therapeutics Drugs Market Trends
15.2 Urological Cancer Therapeutics Drugs Drivers
15.3 Urological Cancer Therapeutics Drugs Market Challenges
15.4 Urological Cancer Therapeutics Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Urological Cancer Therapeutics Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Urological Cancer Therapeutics Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Urological Cancer Therapeutics Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Urological Cancer Therapeutics Drugs Revenue Share by Region (2016-2021)
Table 8. Global Urological Cancer Therapeutics Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Urological Cancer Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Urological Cancer Therapeutics Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Urological Cancer Therapeutics Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Urological Cancer Therapeutics Drugs Sales Share by Company (2016-2021)
Table 14. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Urological Cancer Therapeutics Drugs Revenue Share by Company (2016-2021)
Table 16. Global Urological Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urological Cancer Therapeutics Drugs as of 2020)
Table 17. Global Urological Cancer Therapeutics Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Urological Cancer Therapeutics Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Urological Cancer Therapeutics Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2016-2021)
Table 23. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Urological Cancer Therapeutics Drugs Sales Share by Type (2022-2027)
Table 26. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2022-2027)
Table 28. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2016-2021)
Table 31. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Urological Cancer Therapeutics Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Urological Cancer Therapeutics Drugs Sales Share by Application (2022-2027)
Table 35. Global Urological Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2022-2027)
Table 37. Global Urological Cancer Therapeutics Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 62. China Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 64. China Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 68. China Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 70. China Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 72. China Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 98. India Urological Cancer Therapeutics Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Urological Cancer Therapeutics Drugs Sales Market Share by Company (2016-2021)
Table 100. India Urological Cancer Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Urological Cancer Therapeutics Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Urological Cancer Therapeutics Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2021)
Table 104. India Urological Cancer Therapeutics Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Urological Cancer Therapeutics Drugs Sales Market Share by Type (2022-2027)
Table 106. India Urological Cancer Therapeutics Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2021)
Table 108. India Urological Cancer Therapeutics Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Urological Cancer Therapeutics Drugs Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Novartis Urological Cancer Therapeutics Drugs Product
Table 114. Novartis Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Pfizer Urological Cancer Therapeutics Drugs Product
Table 119. Pfizer Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Johnson & Johnson Urological Cancer Therapeutics Drugs Product
Table 124. Johnson & Johnson Recent Development
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. AstraZeneca Urological Cancer Therapeutics Drugs Product
Table 129. AstraZeneca Recent Development
Table 130. Astellas Corporation Information
Table 131. Astellas Description and Business Overview
Table 132. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Astellas Urological Cancer Therapeutics Drugs Product
Table 134. Astellas Recent Development
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Abbott Laboratories Corporation Information
Table 141. Abbott Laboratories Description and Business Overview
Table 142. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Abbott Laboratories Urological Cancer Therapeutics Drugs Product
Table 144. Abbott Laboratories Recent Development
Table 145. Celgene Corporation Corporation Information
Table 146. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Celgene Corporation Description and Business Overview
Table 148. Celgene Corporation Urological Cancer Therapeutics Drugs Product
Table 149. Celgene Corporation Recent Development
Table 150. Dendreon Corporation Corporation Information
Table 151. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Dendreon Corporation Description and Business Overview
Table 153. Dendreon Corporation Urological Cancer Therapeutics Drugs Product
Table 154. Dendreon Corporation Recent Development
Table 155. Ferring Pharmaceuticals Corporation Information
Table 156. Ferring Pharmaceuticals Description and Business Overview
Table 157. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product
Table 159. Ferring Pharmaceuticals Recent Development
Table 160. GlaxoSmithKline plc Corporation Information
Table 161. GlaxoSmithKline plc Description and Business Overview
Table 162. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product
Table 164. GlaxoSmithKline plc Recent Development
Table 165. Indevus Pharmaceuticals Inc Corporation Information
Table 166. Indevus Pharmaceuticals Inc Description and Business Overview
Table 167. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product
Table 169. Indevus Pharmaceuticals Inc Recent Development
Table 170. Ipsen Corporation Information
Table 171. Ipsen Description and Business Overview
Table 172. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Ipsen Urological Cancer Therapeutics Drugs Product
Table 174. Ipsen Recent Development
Table 175. Roche Healthcare Corporation Information
Table 176. Roche Healthcare Description and Business Overview
Table 177. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Roche Healthcare Urological Cancer Therapeutics Drugs Product
Table 179. Roche Healthcare Recent Development
Table 180. Sanofi S.A. Corporation Information
Table 181. Sanofi S.A. Description and Business Overview
Table 182. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Sanofi S.A. Urological Cancer Therapeutics Drugs Product
Table 184. Sanofi S.A. Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Urological Cancer Therapeutics Drugs Distributors List
Table 188. Urological Cancer Therapeutics Drugs Customers List
Table 189. Urological Cancer Therapeutics Drugs Market Trends
Table 190. Urological Cancer Therapeutics Drugs Market Drivers
Table 191. Urological Cancer Therapeutics Drugs Market Challenges
Table 192. Urological Cancer Therapeutics Drugs Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Product Picture
Figure 2. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Xofigo (radium Ra 223 dichloride) Product Picture
Figure 4. Jevtana (cabazitaxel) Product Picture
Figure 5. Inlyta (axitinib) Product Picture
Figure 6. Votrient (pazopanib hydrochloride) Product Picture
Figure 7. Sutent (sunitinib malate) Product Picture
Figure 8. Zytiga (abiraterone acetate) Product Picture
Figure 9. Xtandi (enzalutamide) Product Picture
Figure 10. Opdivo (nivolumab) Product Picture
Figure 11. Provenge (sipuleucel-T) Product Picture
Figure 12. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2021 & 2027
Figure 13. Hospital Examples
Figure 14. Medical Research Laboratory Examples
Figure 15. Others Examples
Figure 16. Global Urological Cancer Therapeutics Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Urological Cancer Therapeutics Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 18. Global Urological Cancer Therapeutics Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 19. Global Urological Cancer Therapeutics Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 20. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 21. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 22. North America Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. North America Urological Cancer Therapeutics Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 24. Europe Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Europe Urological Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. China Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. China Urological Cancer Therapeutics Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 28. Japan Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Japan Urological Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. Southeast Asia Urological Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 32. India Urological Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. India Urological Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 34. Global 5 Largest Urological Cancer Therapeutics Drugs Players Market Share by Revenue in Urological Cancer Therapeutics Drugs: 2016 & 2020
Figure 35. Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 36. Global Urological Cancer Therapeutics Drugs Revenue Share by Type (2016-2021)
Figure 37. Global Urological Cancer Therapeutics Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Global Urological Cancer Therapeutics Drugs Revenue Share by Application (2016-2021)
Figure 39. Global Urological Cancer Therapeutics Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 41. North America Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 42. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 43. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 44. China Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 45. China Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 46. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 47. Japan Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 48. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 49. Southeast Asia Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 50. India Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 51. India Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs
Figure 54. Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs
Figure 55. Urological Cancer Therapeutics Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed